13th European Congress: Perspectives in Lung Cancer -- Continuing Medical Education Conference

Share Article

For more information about this exciting oncology CME and to register for the 13th European Congress: Perspectives in Lung Cancer on 9-10 March 2012 in Amsterdam, The Netherlands at the Amsterdam RAI Convention Centre. Email us at registration(at)imedex(dot)com. Call us at 1-512-583-8385 or online at http://perspectivesinlungcancer.com. Early registration ends on 12 January 2012. About Imedex, LLC Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

News Image

Past News Releases

RSS

Imedex, LLC will present the 13th European Congress: Perspectives in Lung Cancer meeting on 9-10 March 2012 at the RAI Convention Centre in Amsterdam, The Netherlands. This continuing education opportunity (CME) will cater to a target audience of medical and radiation oncologists, thoracic surgeons, pulmonologists, physicians in- training and other healthcare professionals in active clinical practice, who interested or involved in the management of patients with thoracic cancer. With nearly 1,000 physicians, nurses, and other healthcare professionals attending the Perspectives in Lung Cancer conference annually, this oncology CME opportunity should not be missed!

This continuing medical education opportunity will feature an interactive elements that allow speakers and audience members the ability to exchange information through a “hands-on” computerized speaker-audience interaction system. As participants answer multiple-choice questions their selections are calculated and graphed in real-time, and projected on-screen for all to see. This visual system allows attendees from diverse disciplines to recognize differing opinions and the opportunity to build consensus between the speakers and one another.

After successful completion of this oncology CME opportunity, participants should be able to:

  •     Evaluate the use of biomarkers for the molecular diagnosis of lung cancer and predict the efficacy of targeted agents
  •     Describe and evaluate emerging early detection strategies for lung cancer in Europe
  •     Compare and contrast invasive versus non-invasive (MRI, CT, PET) procedures in the staging of lung cancer
  •     Discuss issues and controversies related to the evolving treatment paradigms in front line metastatic NSCLC
  •     Examine the role of radiotherapy and emerging radiotherapeutic techniques in lung cancer
  •     Summarize the clinical use of systemic therapies in early-stage lung cancer treatment and incorporate them into practice
  •     Describe new agents in the treatment of thoracic malignancies, and increase the frequency with which biologically distinct patients are enrolled into appropriate clinical trials
  •     Analyze the current therapeutic management of mesothelioma and unique populations of patients with thoracic malignancies throughout Europe

For more information about this exciting oncology cme and to register for the 13th European Congress: Perspectives in Lung Cancer on 9-10 March 2012 in Amsterdam, The Netherlands at the Amsterdam RAI Convention Centre.

Email us at registration(at)imedex(dot)com
Call us at 1-512-583-8385
or
Online at http://perspectivesinlungcancer.com

Early registration ends on 12 January 2012.

For event updates, connect with us! Find us on:
Facebook at http://www.facebook.com/pages/European-Perspectives-in-Lung-Cancer-13th-European-Congress/231793266878047
or
Twitter @lungcancercme

For more Imedex events and updates, visit our blog at http://oncologycme.tumblr.com or go to http://www.imedex.com.

About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.

Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine.®

Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at: http://www.audiencegeneration.com.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Marilyn Holman
Audience Generation
512-708-4678
Email >
Visit website